期刊文献+

无抽搐电休克治疗与碳酸锂对双相障碍抑郁发作患者氧化应激水平的影响 被引量:30

The effect of modified electroconvulsive therapy and lithium on oxidative stress status in bipolar disorder patients with depression episode
下载PDF
导出
摘要 目的了解无抽搐电休克治疗(modified electroconvulsive therapy,MECT)对双相障碍抑郁发作患者氧化应激水平的影响。方法选取双相障碍抑郁发作患者42例,随机分为两组,MECT组18例患者在抗抑郁药物治疗基础上行12次MECT治疗,碳酸锂组24例患者使用碳酸锂合并抗抑郁药物治疗,共治疗6周。分别在治疗前、治疗6周末采用17项汉密尔顿抑郁量表(17 items Hamilton depression scale,HAMD-17)、杨氏躁狂量表(Young mania rating scale,YMRS)、临床疗效总评量表(clinical global impression scale,CGI)、副反应量表(treatment emergent symptom scale,TESS)评估疗效和不良反应,检测外周血超氧化物歧化酶(superoxide dismutase,SOD)、过氧化氢酶(catalase,CAT)、谷胱甘肽过氧化物酶(glutathione peroxidase,GSH-Px)、丙二醛(malondialdehyde,MDA)含量,评估氧化应激水平。结果重复测量方差分析显示,SOD指标分组主效应有统计学意义(F=15.26,P<0.01),碳酸锂组的水平整体高于MECT组(P<0.05);MDA指标分组主效应有统计学意义(F=18.18,P<0.01),MECT组的水平整体高于碳酸锂组(P<0.05);GSH-Px指标分组主效应(F=6.24,P=0.02)、分组与时间交互效应(F=6.39,P=0.02)有统计学意义,碳酸锂组的水平整体高于MECT组(P<0.05),治疗前两组间无统计学差异(P>0.05),治疗6周末MECT组GSH-Px低于碳酸锂组(P<0.05)。治疗6周末,MECT组中治疗有效者CAT水平较无效者高(P<0.05)。结论 MECT能改变双相障碍抑郁发作患者氧化应激水平,其对血浆CAT的调节可能是治疗有效的作用机制之一。 Objective To examine the effect of modified electroconvulsive therapy (MECT) on the plasma oxidative stress level in bipolar depression. Methods Forty-two patients with bipolar depression were randomly divided into two groups. The intervention group (n=18) received antidepressants and 12 times MECT for 6 weeks and the control group (n=24) received antidepressants and Li2CO3 for 6 weeks. The Chinese versions of the 17 items Hamilton Depression Rating Scale (HAMD-17), Young Mania Rating Scale (YMRS), Clinical Global Impression Scale (CGI-S) and Treatment Emergent Symptom Scale (TESS) were used to assess participants at baseline and after 6 weeks of treatment. The plasma levels of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px) and malondialdehyde (MDA) were detected at baseline and after 6 weeks to assess the level of oxidative stress. Results Repeated measures analysis of variance showed that the plasma level of SOD was higher in MECT group than in Li2CO3 group (F=15.26, P〈0.01), and the level of MDA was higher in Li2CO3 group (F=18.18, P〈0.01). The interactive effect of group and time was significant in GSH-Px level (F=6.39, P=0.02). The level of GSH-Px was lower in MECT group than in Li2CO3 group after 6 weeks (P〈0.05). The CAT level was higher in the response patients than in non-response patients after 6 weeks (P〈0.05). Con- clusions Both MECT treatment and Li2CO3 treatment can alter oxidative stress levels in patients with bipolar depression. The mechanisms underlying its therapeutic regimen may correct the imbalance of the plasma CAT level.
作者 吕钦谕 鲍晨曦 陆燕华 路伟 胡海琦 易正辉 何永光 LV Qinyu BAO Chenxi LU Yanhua LU Wei HU Haiqi YI Zhenghui HE Yong- guang.(Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai 200030, China)
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2016年第12期731-736,共6页 Chinese Journal of Nervous and Mental Diseases
基金 上海市精神卫生中心院级课题(编号:2014-YJ-04 2015-YJGJ-02) 国家自然科学基金(编号:81671326) 上海市精神疾病临床医学中心(编号:2014)
关键词 双相情感障碍 氧化应激 无抽搐电休克治疗 碳酸锂 Bipolar disorder Oxidative stress Modified electroconvulsive therapy Lithium
  • 相关文献

参考文献1

二级参考文献25

  • 1Murray CJL,Lopez AD.The global burden of disease:A comprehensive assessment of mortality and disability from diseases,injuries,and risk factors in 1990 and projected to 2020[M].Cambridge,MA:Harvard University Press,1996:1-977.
  • 2Ormel J,Petukhova M,Chatterji S,et al.Disability and treatment of specific mental and physical disorders across the world:Results from the WHO World Mental Health Surveys[J].Br J Psychiatry,2008,192(5):368-375.
  • 3Cohen J.The global burden of disease study:A useful projection of future global health?[J].J Public Health Med,2000,22(4):518-524.
  • 4Canino GJ,Bird HR,Shrout PE,et al.The prevalence of specific psychiatric disorders in Puerto Rico[J].Arch Gen Psychiatry,1987,44(8):727-735.
  • 5Wells JE,Bushnell JA,Hornblow AR,et al.Christchurch psychiatric epidemiology study,part I:methodology and lifetime prevalence for specific psychiatric disorders[J].Aust N Z J Psychiatry,1989,23(3):315-326.
  • 6Wittchen HU,Essau CA,von Zerssen D,et al.Lifetime and six-month prevalence of mental disorders in the munich follow-up study[J].Eur Arch Psychiatry Clin Neurosci,1992,241(4):247-258.
  • 7Chen CN,Wong J,Lee N,et al.The Shatin community mental health survey in Hong Kong.II.major findings[J].Arch Gen Psychiatry,1993,50(2):125-133.
  • 8Kessler RC,McGonagle KA,Zhao S,et al.Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States:Results from the national comorbidity survey[J].Arch Gen Psychiatry,1994,51(1):8-19.
  • 9Wang PS,Demler O,Kessler RC.Adequacy of treatment for serious mental illness in the United States[J].Am J Public Health,2002,92(1):92-98.
  • 10Narrow WE,Rae DS,Robins LN,et al.Revised prevalence estimates of mental disorders in the United States:Using a clinical significance criterion to reconcile 2 surveys' estimates[J].Arch Gen Psychiatry,2002,59(2):115-123.

共引文献37

同被引文献264

引证文献30

二级引证文献171

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部